Cellular & Molecular Immunology is a bimonthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.The journal publishes Research Articles, Reviews, Minireviews and Brief Reports in all areas of cellular and molecular immunology, including but not limited to: * clinical immunology * comparative immunology * immunobiology * immunogenetics * immunological techniques * immunopathology * immunopharmacology * infection immunology * neuroimmunology * transplantation immunology * tumor immunology * veterinary immunologyAs China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.Manuscripts must provide evidence that can be critically evaluated, and where applicable: * define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.) * deem results 'significant' only using standard statistical methods in biological effects/outcomes studies * use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.
Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical & Experimental Allergy and included with every subscription to the primary research journal.
Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease.Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.Free Access in the Developing WorldFree online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).Online OpenAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.
Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:• Ageing• Allergy• Autoimmunity• Biotechnology• Clinical Laboratory Immunology• HIV• Immunodermatology• Immunohematology• Immunotoxicology/Environmental• Infection and Immunity• Mucosal Immunity• Neuroimmunology• Primary Immunodeficiency• Transplantation• Tumor Immunology• VaccinesBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com